Treatment of Hypercalcemia of Malignancy With Intravenous Etidronate: A Controlled, Multicenter Study

Frederick R. Singer, Paul S. Ritch, Thomas E. Lad, Q. Scott Ringenberg, Joan H. Schiller, Robert R. Recker, Elisabeth Ryzen, Claude S. Arnaud, Michael D. Draper, Gordon J. Strewler, John M. Bennett, Joanne R. Carignan, Craig S. McCune, Raman Qazi, Patrick J. Byrne, Peder Charles, Claus Hasling, Leif Mosekilde, Ronald C. DeConti, Gregory R. HarperJohn Horton, John C. Ruckdeschel, Alexander S. Spiers, Lee M. Zehngebot, David S. Ettinger, Martin D. Abeloff, Michael D. Green, Howard S. Hochster, Harold A. Harvey, Allan Lipton, Mary A. Simmonds, Subhash Kukreja, Daniel Shevrin, Michael R. McClung, Nancy Kane-Johnson, Eric S. Orwoll, Lawrence C. Panasci, Walter A. Brzezinski, Tom Anderson, Marjorie A. Vukelich, Al B. Benson, Thomas E. Davis, James K. Willson, Manuel Fernandez, Robert K. Rude

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Treatment of Hypercalcemia of Malignancy With Intravenous Etidronate: A Controlled, Multicenter Study

Fingerprint

Medicine & Life Sciences